|
|
 |
SENSEX
|
 |
-213.65
|
-0.85%
|
24870.10
|
|
|
NIFTY
|
 |
-693.86
|
-0.85%
|
81306.85
|
|
|
Nasdaq
|
 |
396.23
|
1.88%
|
21496.54
|
|
|
Nikkei 225
|
 |
23.12
|
0.05%
|
42633.29
|
|
|
FTSE 100
|
 |
12.20
|
0.13%
|
9321.40
|
|
|
 |
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
BSE Code |
540222
|
ISIN Demat |
INE947Q01028
|
Book Value (Rs) |
86.99
|
|
NSE Code |
LAURUSLABS
|
Dividend Yield % |
0.14
|
Market Cap (Rs) |
474290.16
|
|
TTM PE(x) |
93.08
|
TTM EPS(Rs) |
9.44
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
Incorporation Year
|
19-09 2005
|
Registered Office
|
Laurus Enclave, Plot Office 01,Edulapaka Bonangi Village, Parawada,Mandal, Anakapalli, Vishakhapatnam, Andhra Pradesh-531021 .
|
ISINNO
|
INE947Q01028
|
Phone
|
0891 6821101 / 1102
|
E-mail
|
info@lauruslabs.com |
URL
|
www.lauruslabs.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Ravindranath Kancherla
|
Managing Director
|
|
Company Secretary
|
G Venkateswar Reddy
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|